Litcius/Paper detail

Mendelian randomization study for the roles of IL-18 and IL-1 receptor antagonist in the development of inflammatory bowel disease

Jiarui Mi, Zhengye Liu, Shengduo Pei, Xia Wu, Nan Zhao, Lingjuan Jiang, Zhenjie Zhang, Xiaoyin Bai

2022International Immunopharmacology18 citationsDOI

Topics & Concepts

Mendelian randomizationSingle-nucleotide polymorphismOdds ratioGenome-wide association studyInterleukin 1 receptor antagonistInflammatory bowel diseaseDiseaseBiologyMedicineInternal medicineImmunologyGeneticsGenotypeReceptor antagonistGeneReceptorAntagonistGenetic variantsInflammasome and immune disordersInflammatory Bowel DiseaseGenetic Associations and Epidemiology
Mendelian randomization study for the roles of IL-18 and IL-1 receptor antagonist in the development of inflammatory bowel disease | Litcius